Search | VHL Search Portal

1.

Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL.

Shen, Yandong; Freeman, Jane A; Kerridge, Ian; Downe, Paul; Naidu, Kartik; Holland, Juliette; Mulligan, Stephen P.

Br J Haematol ; 204(2): 487-491, 2024 02.

Article in English | MEDLINE | ID: mdl-37669920

2.

Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.

Shen, Yandong; Freeman, Jane A; Holland, Juliette; Naidu, Kartik; Solterbeck, Ann; Van Bilsen, Nenna; Downe, Paul; Kerridge, Ian; Wallman, Lucinda; Akerman, Anouschka; Aggarwal, Anupriya; Milogiannakis, Vanessa; Martins Costa Gomes, Gabriela; Doyle, Chloe M; Sandgren, Kerrie J; Turville, Stuart; Cunningham, Anthony L; Mulligan, Stephen P.

Blood ; 140(25): 2709-2721, 2022 12 22.

Article in English | MEDLINE | ID: mdl-36206503

3.

Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.

Campbell, Ashlea; Teh, Benjamin; Mulligan, Stephen; Ross, David M; Weinkove, Robert; Gilroy, Nicole; Gangatharan, Shane; Prince, Henry Miles; Szer, Jeff; Trotman, Judith; Lane, Steven; Dickinson, Michael; Quach, Hang; Enjeti, Anoop K; Ku, Matthew; Gregory, Gareth; Hapgood, Gregory; Ho, Phoebe Joy; Cochrane, Tara; Cheah, Chan; Greenwood, Matthew; Latimer, Maya; Berkahn, Leanne; Wight, Joel; Armytage, Tasman; Diamond, Peter; Tam, Constantine S; Hamad, Nada.

Intern Med J ; 54(2): 328-336, 2024 Feb.

Article in English | MEDLINE | ID: mdl-38146232

4.

Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemia.

Salvaris, Ross; Mulligan, Stephen; Puig, Andrea; McGeachie, Marija; Opat, Stephen.

Intern Med J ; 53(11): 2115-2118, 2023 Nov.

Article in English | MEDLINE | ID: mdl-37950615

5.

Chronic lymphocytic leukaemia Australasian consensus practice statement.

Anderson, Mary A; Bennett, Rory; Badoux, Xavier; Best, Giles; Chia, Nicole; Cochrane, Tara; Cull, Gavin; Crassini, Kyle; Harrup, Rosemary; Jackson, Sharon; Kuss, Bryone; Lasica, Masa; Lew, Thomas E; Marlton, Paula; Opat, Stephen; Palfreyman, Emma; Polizzotto, Mark N; Ratnasingam, Sumita; Seymour, John F; Soosapilla, Asha; Talaulikar, Dipti; Tam, Constantine S; Weinkove, Robert; Wight, Joel; Mulligan, Stephen P.

Intern Med J ; 53(9): 1678-1691, 2023 09.

Article in English | MEDLINE | ID: mdl-37743239

6.

COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity.

Shen, Yandong; Freeman, Jane A; Holland, Juliette; Solterbeck, Ann; Naidu, Kartik; Soosapilla, Asha; Downe, Paul; Tang, Catherine; Kerridge, Ian; Wallman, Lucinda; Van Bilsen, Nenna; Milogiannakis, Vanessa; Akerman, Anouschka; Martins Costa Gomes, Gabriela; Sandgren, Kerrie; Cunningham, Anthony L; Turville, Stuart; Mulligan, Stephen P.

Br J Haematol ; 197(1): 41-51, 2022 04.

Article in English | MEDLINE | ID: mdl-34962656

7.

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.

Tam, Constantine S; Opat, Stephen; D'Sa, Shirley; Jurczak, Wojciech; Lee, Hui-Peng; Cull, Gavin; Owen, Roger G; Marlton, Paula; Wahlin, Björn E; Sanz, Ramón Garcia; McCarthy, Helen; Mulligan, Stephen; Tedeschi, Alessandra; Castillo, Jorge J; Czyz, Jaroslaw; Fernández de Larrea, Carlos; Belada, David; Libby, Edward; Matous, Jeffrey V; Motta, Marina; Siddiqi, Tanya; Tani, Monica; Trneny, Marek; Minnema, Monique C; Buske, Christian; Leblond, Veronique; Trotman, Judith; Chan, Wai Y; Schneider, Jingjing; Ro, Sunhee; Cohen, Aileen; Huang, Jane; Dimopoulos, Meletios.

Blood ; 136(18): 2038-2050, 2020 10 29.

Article in English | MEDLINE | ID: mdl-32731259

8.

Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.

Keegan, Anastazia; Dennington, Peta M; Dhondy, Nina; Mulligan, Stephen P.

Eur J Haematol ; 108(6): 460-468, 2022 Jun.

Article in English | MEDLINE | ID: mdl-35152500

9.

Insight into del17p low-frequency subclones in chronic lymphocytic leukaemia (CLL): data from the Australasian Leukaemia and Lymphoma Group (ALLG)/CLL Australian Research Consortium (CLLARC) CLL5 trial.

Do, Cuc; Best, O Giles; Thurgood, Lauren; Hotinski, Anya; Apostolou, Sinoula; Mulligan, Stephen P; Lower, Karen; Kuss, Bryone.

Br J Haematol ; 193(3): 556-560, 2021 05.

Article in English | MEDLINE | ID: mdl-33851417

10.

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.

Byrd, John C; Hillmen, Peter; O'Brien, Susan; Barrientos, Jacqueline C; Reddy, Nishitha M; Coutre, Steven; Tam, Constantine S; Mulligan, Stephen P; Jaeger, Ulrich; Barr, Paul M; Furman, Richard R; Kipps, Thomas J; Thornton, Patrick; Moreno, Carol; Montillo, Marco; Pagel, John M; Burger, Jan A; Woyach, Jennifer A; Dai, Sandra; Vezan, Remus; James, Danelle F; Brown, Jennifer R.

Blood ; 133(19): 2031-2042, 2019 05 09.

Article in English | MEDLINE | ID: mdl-30842083

11.

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.

McCaughan, Georgia; Di Ciaccio, Pietro; Ananda-Rajah, Michelle; Gilroy, Nicole; MacIntyre, Raina; Teh, Benjamin; Weinkove, Robert; Curnow, Jennifer; Szer, Jeff; Enjeti, Anoop K; Ross, David M; Mulligan, Stephen; Trotman, Judith; Dickinson, Michael; Quach, Hang; Choi, Phillip; Polizzotto, Mark N; Tam, Constantine S; Ho, P Joy; Ku, Matthew; Gregory, Gareth; Gangatharan, Shane; Hapgood, Greg; Cochrane, Tara; Cheah, Chan; Gibbs, Simon; Wei, Andrew; Johnston, Anna; Greenwood, Matthew; Prince, H Miles; Latimer, Maya; Berkahn, Leanne; Wight, Joel; Armytage, Tasman; Hamad, Nada.

Intern Med J ; 51(5): 763-768, 2021 05.

Article in English | MEDLINE | ID: mdl-34047035

12.

Karyotype and outcome in CLL.

Mulligan, Stephen P.

Blood ; 142(5): 402-404, 2023 08 03.

Article in English | MEDLINE | ID: mdl-37535371

13.

Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.

Weinkove, Robert; McQuilten, Zoe K; Adler, Jonathan; Agar, Meera R; Blyth, Emily; Cheng, Allen C; Conyers, Rachel; Haeusler, Gabrielle M; Hardie, Claire; Jackson, Christopher; Lane, Steven W; Middlemiss, Tom; Mollee, Peter; Mulligan, Stephen P; Ritchie, David; Ruka, Myra; Solomon, Benjamin; Szer, Jeffrey; Thursky, Karin A; Wood, Erica M; Worth, Leon J; Yong, Michelle K; Slavin, Monica A; Teh, Benjamin W.

Med J Aust ; 212(10): 481-489, 2020 06.

Article in English | MEDLINE | ID: mdl-32401360

14.

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.

Di Ciaccio, Pietro; McCaughan, Georgia; Trotman, Judith; Ho, Phoebe Joy; Cheah, Chan Y; Gangatharan, Shane; Wight, Joel; Ku, Matthew; Quach, Hang; Gasiorowski, Robin; Polizzotto, Mark N; Prince, Henry Miles; Mulligan, Stephen; Tam, Constantine S; Gregory, Gareth; Hapgood, Greg; Spencer, Andrew; Dickinson, Michael; Latimer, Maya; Johnston, Anna; Armytage, Tasman; Lee, Cindy; Cochrane, Tara; Berkhahn, Leanne; Weinkove, Robert; Doocey, Richard; Harrison, Simon J; Webber, Nicholas; Lee, Hui-Peng; Chapman, Scott; Campbell, Belinda A; Gibbs, Simon D J; Hamad, Nada.

Intern Med J ; 50(6): 667-679, 2020 06.

Article in English | MEDLINE | ID: mdl-32415723

15.

Molecular pathogenesis of chronic lymphocytic leukaemia.

Crassini, Kyle; Stevenson, William S; Mulligan, Stephen P; Best, O Giles.

Br J Haematol ; 186(5): 668-684, 2019 09.

Article in English | MEDLINE | ID: mdl-31364161

16.

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.

Barr, Paul M; Brown, Jennifer R; Hillmen, Peter; O'Brien, Susan; Barrientos, Jacqueline C; Reddy, Nishitha M; Coutre, Steven; Mulligan, Stephen P; Jaeger, Ulrich; Furman, Richard R; Cymbalista, Florence; Montillo, Marco; Dearden, Claire; Robak, Tadeusz; Moreno, Carol; Pagel, John M; Burger, Jan A; Suzuki, Samuel; Sukbuntherng, Juthamas; Cole, George; James, Danelle F; Byrd, John C.

Blood ; 129(19): 2612-2615, 2017 05 11.

Article in English | MEDLINE | ID: mdl-28373262

17.

Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Munir, Talha; Brown, Jennifer R; O'Brien, Susan; Barrientos, Jacqueline C; Barr, Paul M; Reddy, Nishitha M; Coutre, Steven; Tam, Constantine S; Mulligan, Stephen P; Jaeger, Ulrich; Kipps, Thomas J; Moreno, Carol; Montillo, Marco; Burger, Jan A; Byrd, John C; Hillmen, Peter; Dai, Sandra; Szoke, Anita; Dean, James P; Woyach, Jennifer A.

Am J Hematol ; 94(12): 1353-1363, 2019 12.

Article in English | MEDLINE | ID: mdl-31512258

18.

Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.

Ruchlemer, Rosa; Ben-Ami, Ronen; Bar-Meir, Maskit; Brown, Jennifer R; Malphettes, Marion; Mous, Rogier; Tonino, Sanne H; Soussain, Carole; Barzic, Noelie; Messina, Julia A; Jain, Preetesh; Cohen, Regev; Hill, Brian; Mulligan, Stephen P; Nijland, Marcel; Herishanu, Yair; Benjamini, Ohad; Tadmor, Tamar; Okamoto, Koh; Arthurs, Benjamin; Gottesman, Batsheva; Kater, Arnon P; Talha, Munir; Eichhorst, Barbara; Korem, Maya; Bogot, Naama; De Boer, Fransien; Rowe, Jacob M; Lachish, Tamar.

Mycoses ; 62(12): 1140-1147, 2019 Dec.

Article in English | MEDLINE | ID: mdl-31520441

19.

MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.

Crassini, Kyle; Shen, Yandong; Stevenson, William S; Christopherson, Richard; Ward, Chris; Mulligan, Stephen P; Best, O Giles.

Br J Haematol ; 182(3): 360-372, 2018 08.

Article in English | MEDLINE | ID: mdl-29767411

20.

The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment.

Crassini, Kyle; Shen, Yandong; O'Dwyer, Michael; O'Neill, Michael; Christopherson, Richard; Mulligan, Stephen; Best, O Giles.

Br J Haematol ; 182(5): 654-669, 2018 09.

Article in English | MEDLINE | ID: mdl-29978459

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: